FOXD1-activated ANXA3 facilitates cisplatin resistance of lung cancer cells via promoting ANXA4 expression.

Saved in:
Bibliographic Details
Title: FOXD1-activated ANXA3 facilitates cisplatin resistance of lung cancer cells via promoting ANXA4 expression.
Authors: Tan Q; Department of Respiratory and Critical Care Medicine, No. 926 Hospital, Joint Logistics Support Force of PLA, No. 147 Jianmin Road, Kaiyuan City, Honghe Hani and Yi Autonomous Prefecture, Yunnan Province, China., Gao D; Department of Oncology, The Dongtai Hospital of Nantong University, 2 Kangfu West Road Dongtai, Nantong, Jiangsu, 224200, China., Hu X; Department of TCM, Tongde Hospital of Zhejiang Province, 234 Gucui Road, Xihu District, Hangzhou City, Zhejiang Province, China. Huxu18758068785@126.com.
Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2025 Sep; Vol. 398 (9), pp. 11989-12001. Date of Electronic Publication: 2025 Mar 17.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-1912
DOI:10.1007/s00210-025-04005-1